Chloramphenicol muscle residue levels in rainbow trout were determined after oral administration of 84 μg kg
Chloramphenicol is a broad-spectrum antibiotic with well-known bacteriostatic properties effective against both gram-positive and gram-negative bacteria, as well as against other groups of microorganisms. Chloramphenicol binds to the A site of the peptidyltransferase centre, where it disturbs the placement of A site tRNA and thus prevents peptide bond formation (1) . Toxicology reports indicate that chloramphenicol can cause bone-marrow depression, a disorder that is reversible after drug withdrawal. On the other hand, chloramphenicol can also cause irreversible aplastic anaemia that can result in leukaemia (3, 4) . Because of these side effects, in human medicine chloramphenicol is used when less risky drugs are ineffective (2) .
Due to risk for human health, the European Union has prohibited the use of chloramphenicol in foodproducing animals destined for human consumption (5) and set the minimum required performance limit (MRPL) to 0.3 μg kg −1 as the minimum content of chloramphenicol in several matrices, including aquaculture products, to be detected and confi rmed by analytical methods (6) . However, chloramphenicol may still be in use in some developing countries owing to its low cost (7, 8) . Drug residues have been detected in all kinds of animal products imported to the EU, especially in honey, shrimp, and other aquatic animals such as fi sh, mostly of Asian origin. This raises great concern about the impact on consumer health.
Viral and bacterial diseases are common in aquaculture, especially with high stocking densities. In the past, chloramphenicol was used as a chemotherapeutic agent to control diseases or as a prophylaxis or disinfectant to prevent disease, either through direct application into the aquatic environment or through medicated feeds in a mass fraction of (4 to 8) g per 100 kg (9, 10) . Chloramphenicol absorbs well in the gastrointestinal tract and its elimination half-time varies widely between species. Its lipid solubility enables the molecule to persist in most tissues, body fl uids, and the central nervous system, and it readily diffuses to milk and eggs (11) . Chloramphenicol residues in aquaculture products may present a risk to public health, while residues in water and sediment endanger the aquatic environment (12) .
Rainbow trout is the most cultivated freshwater species in aquaculture worldwide. Fish production is increasing annually in countries such as Italy, France, Germany, Denmark and Spain. Large production of fi sh has also been registered in the USA, Iran, Germany and the United Kingdom (13) . However, only a few studies have investigated chloramphenicol elimination in fi sh species before they reach consumers (14, 15) .
The aim of our study was to determine the elimination time of chloramphenicol in rainbow trout after oral treatment with medicated feed over a four-day period using a validated enzyme immunoassay method.
MATERIALS AND METHODS

Fish treatment and sampling
Rainbow trout (Oncorhynchus mykiss) were kept in 4.7 m 3 fi breglass tanks supplied with a constant fl ow of 720 L h −1 of water with oxygen content of (92.8±3.1) % at a temperature of (9.7±0.1) °C, pH (7.5±0.1). The average mass of a trout was (200 to 250) g, n=200.
For a daily chloramphenicol therapeutic dose of 84 mg kg
, feed (500 g pellets) was added 28 mL of chloramphenicol solution (150 mg mL -1 ; Jiangxi Dongxu Chemical Technology Ltd., China) and mixed well to achieve homogeneity of the drug throughout the matrix. Twice a day the fi sh received 0.5 kg of medicated pellets per 100 kg of fi sh.
Samples were taken at random one day before treatment (baseline), and then on day 1 after treatment ended, and on every second (odd) day until day 43 (Table 1) . On each sampling day, three fi sh were taken from a tank, their skin and internal organs removed, and muscle tissues and random subcutaneous fat partly homogenised, packed in plastic bags and stored at -18 °C until analysis.
Reagents and standards
Chloramphenicol kit (type E.G.1) was provided by the Laboratory of Hormonology (Marloie, Belgium) and consisted of a microtitre plate (96 wells), standard solutions of chloramphenicol [(0, 0.05, 0.1, 0.2, 0.5, 1 and 2) ng mL -1 ], concentration conjugate (peroxidase conjugated chloramphenicol), lyophilised antichloramphenicol antibody, substrate/chromogen solution (peroxide/tetramethylbenzidine) dilution buffer (pH 7.4), stop solution (6 N H 2 SO 4 ), and a rinsing buffer.
Chloramphenicol standard was from SigmaAldrich (St. Louis, MO, USA). All reagents were of analytical, HPLC, or LC-MS grade. Methanol, Standard stock solutions were prepared on a weekly basis by dissolving the analyte in methanol. Intermediate working solutions were prepared before each analysis by diluting stock solutions in methanol. Working solutions were used for spiking blank fi sh muscle samples at different levels. Following fortifi cation, samples were allowed to equilibrate for 15 min before extraction.
Sample preparation
A total of 3 g of homogenised fi sh sample was weighed and mixed with 3 mL of distilled water. Chloramphenicol was extracted from the matrix by adding 6 mL of ethyl acetate and mixing with a dispersing system for 10 minutes. After centrifugation (1006 rpm, 10 min), 5 mL supernatant was taken and evaporated with nitrogen until dry at 50 °C. Residues were dissolved with 1 mL isooctane/dichloromethane mixture (2:3) and mixed intensively with 0.5 mL of dissolving buffer (from kit accessories) for 1 min and then centrifuged at 1006 rpm for 10 min. If an emulsion appeared in the upper layer, residues were heated for 2 min in a water bath at 80 °C and centrifuged again. For the EIA test, 50 μL of the upper layer was used. Immunoassays were performed according to the manufacturer's instructions. The absorbance for all assays was measured at 450 nm.
Instrumental
The following instruments were used in sample preparation: 
Statistical analysis
Analysis of variance was performed using the Statistica ® 6.1 software package (StatSoft ® Inc., Tulsa, USA). Results were expressed as mean ± SD. Differences in chloramphenicol concentrations between days were analysed using Student's t-test for independent pairs. Probability values of ≤0.05 were considered statistically signifi cant. 
CV -coeffi cient of variation
RESULTS AND DISCUSSION
Elimination of chloramphenicol was estimated over 43 days after the end of treatment with chloramphenicol in the dose of 84 mg kg -1 day -1 . Analysis was performed by using enzyme linked immunoassay (ELISA) method, in-house validated to the criteria of Commission Decision 2002/657/EC. In the validation study, the detection capability was CCß=0.23 μg kg -1 and the limit of detection (LOD) 0.0008 μg kg -1 . Trueness was expressed in terms of recovery (Rec / %) with a mean value of 93.2 % at three mass fraction levels ( Table 2 ). The coeffi cient of variation (CV / %) for the lowest spiked concentration was 10.6 % (<20 %). Validation parameters indicated that the method was appropriate for detection of chloramphenicol at levels below the MRPL of 0.3 μg kg -1 . Table 1 shows mean mass fractions of chloramphenicol in the muscle of rainbow trout, on baseline and 43 days after the treatment ended. The highest chloramphenicol levels were detected on day 1 after the end of treatment (144.3 μg kg -1 ). Over the next 33 days levels kept dropping from 28.1 μg kg -1 on day 3 to 0.015 μg kg -1 on day 33. Significant elimination took place over the fi rst 7 days after the end of treatment, and signifi cant differences were detected between days 1 and 3 (p< 0.001), 3 and 5 (p<0.001), and 5 and 7 (p<0.05). Between days 33 and 43 after the end of treatment, chloramphenicol levels decreased more slowly from 0.015 μg kg -1 to 0.011 μg kg -1 . In a recent study conducted on rainbow trout receiving chloramphenicol in the dose of 73.9 mg kg -1 d -1 over 10 days (15) , mean chloramphenicol level was 35.781 μg kg -1 on day 1 after the end of treatment. This level is more than 250 times higher than in our study and may be due to a 2.5 times longer treatment period. Moreover, in that study trout were kept in tanks with a constant fl ow of 8 L h -1 , as opposed to a 90 times higher water flow in our study (720 L h -1 ). Accordingly, chloramphenicol levels in our study dropped below MRPL of 0.3 μg kg −1 on day 9 (0.171 μg kg −1 ) after the end of treatment. In the elimination period from day 11 to 43, chloramphenicol residues were detectable in the range from a maximum of 0.091 μg kg −1 to a minimum of 0.011 μg kg −1 . In contrast, in the trout treated over 10 days (15) , chloramphenicol levels were still at 0.3 μg kg -1 31 days after the end of treatment.
In a study on shrimp (Penaeus chinensis) receiving a diet containing 2000 mg kg -1 of chloramphenicol a day over three days, the elimination of chloramphenicol to below MRPL took three days (14) . It may be concluded that withdrawal periods vary widely among species (17) .
High chloramphenicol mass fractions ranging from 0.1 μg kg -1 to 34 μg kg -1 were measured in samples of aquaculture products in Ireland in 2002 (2) . High chloramphenicol average of 0.25 μg kg -1 , (range: 0.06 μg kg -1 to 0.69 μg kg -1 , with two outlying values of 3.0 μg kg -1 and 3.7 μg kg -1 ) was also confi rmed in shrimp samples (2) . During the past decade, chloramphenicol residues ranging from 0.3 μg kg -1 to 3.5 μg kg -1 were reported in fi sh and fi sh products imported to the EU, mainly from China and Vietnam (18) . The highest cloramphenicol value of 3.5 μg kg -1 was measured in Germany in eel imported from China. These data confi rm the intentional use of the drug in products imported from developing countries and call for control of its abuse in aquaculture products.
CONCLUSIONS
Our results show that trout tissue could be compliant for consumption with no potential risk to health after a 10-day withdrawal period.
The method validated and used is very sensitive and able to detect chloramphenicol after the fi rst ten days after treatment. The method is able to protect consumers since it is capable of detecting small concentrations of chloramphenicol. Also, if treatment with chloramphenicol is not permitted in Europe, the use of this method to control fi sh imported from Asian Countries should represent a guarantee that fi sh had undergone a 10-day withdrawal period.
